Stock Events

Stock Events

CRISPR Therapeutics (1CG.MU) Q1 2026 Earnings

12FebConfirmed

Q1 2026

-1.15

-1.1

-1.04

-0.98

Details

Expected EPS

-0.97978302568

Actual EPS

-1.1542798

Surprise EPS

-0.17

Surprise Percent

+17.81%

Description

CRISPR Therapeutics (1CG.MU) has reported earnings of -1.1542798 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.